42 U.S.C. Chapter 6A — PUBLIC HEALTH SERVICE
- § 201— Definitions
- § 202— Administration and supervision of Service
- § 203— Organization of Service
- § 204— Commissioned Corps and Ready Reserve Corps
- § 204a— Deployment readiness
- § 205— Appointment and tenure of office of Surgeon General; reversion in rank
- § 206— Assignment of officers
- § 207— Grades, ranks, and titles of commissioned corps
- § 209— Appointment of personnel
- § 209d— Appointment of osteopaths as commissioned officers
- § 210— Pay and allowances
- § 210–1— Annual and sick leave
- § 210b— Professional categories
- § 211— Promotion of commissioned officers
- § 211c— Promotion credit for medical officers in assistant grade
- § 212— Retirement of commissioned officers
- § 213— Military benefits
- § 213a— Rights, benefits, privileges, and immunities for commissioned officers or beneficiaries; exercise of authority by Secretary or designee
- § 214— Presentation of United States flag upon retirement
- § 215— Detail of Service personnel
- § 216— Regulations
- § 217— Use of Service in time of war or emergency
- § 217a— Advisory councils or committees
- § 217a–1— Advisory committees; prohibition of consideration of political affiliations
- § 217b— Volunteer services
- § 218— National Advisory Councils on Migrant Health
- § 218a— Training of officers
- § 231— Service and supply fund; uses; reimbursement
- § 232— National Institute of Mental Health; authorization of appropriation; construction; location
- § 233— Civil actions or proceedings against commissioned officers or employees
- § 234— Health care professionals assisting during a public health emergency
- § 235— Administration of grants in multigrant projects; promulgation of regulations
- § 236— Orphan Products Board
- § 237— Silvio O. Conte Senior Biomedical Research and Biomedical Product Assessment Service
- § 237a— Health and Human Services Office on Women’s Health
- § 238— Gifts for benefit of Service
- § 238a— Use of immigration station hospitals
- § 238b— Disposition of money collected for care of patients
- § 238c— Transportation of remains of officers
- § 238d— Availability of appropriations for grants to Federal institutions
- § 238e— Transfer of funds
- § 238f— Availability of appropriations
- § 238g— Wearing of uniforms
- § 238h— Biennial report
- § 238i— Memorials and other acknowledgments for contributions to health of Nation
- § 238j— Evaluation of programs
- § 238k— Contract authority
- § 238l— Recovery
- § 238m— Use of fiscal agents
- § 238n— Abortion-related discrimination in governmental activities regarding training and licensing of physicians
- § 238o— Restriction on use of funds for assisted suicide, euthanasia, and mercy killing
- § 238p— Recommendations and guidelines regarding automated external defibrillators for Federal buildings
- § 238q— Liability regarding emergency use of automated external defibrillators
- § 239— General provisions
- § 239a— Determination of eligibility and benefits
- § 239b— Smallpox vaccine injury table
- § 239c— Medical benefits
- § 239d— Compensation for lost employment income
- § 239e— Payment for death
- § 239f— Administration
- § 239g— Authorization of appropriations
- § 239h— Relationship to other laws
- § 239l— Establishment
- § 239l–1— Administration
- § 239l–2— Students; selection; obligation
- § 239l–3— Funding
- § 241— Research and investigations generally
- § 242— Studies and investigations on use and misuse of narcotic drugs and other drugs; annual report to Attorney General; cooperation with States
- § 242b— General authority respecting research, evaluations, and demonstrations in health statistics, health services, and health care technology
- § 242c— Appointment and authority of the Director of the Centers for Disease Control and Prevention
- § 242c–1— Advisory committee to the Director
- § 242k— National Center for Health Statistics
- § 242l— International cooperation
- § 242m— General provisions respecting effectiveness, efficiency, and quality of health services
- § 242o— Health conferences; publication of health educational information
- § 242p— National disease prevention data profile
- § 242q— Task Force on Aging Research; establishment and duties
- § 242q–1— Membership
- § 242q–2— Administrative staff and support
- § 242q–4— Definitions
- § 242q–5— Authorization of appropriations
- § 242r— Improvement and publication of data on food-related allergic responses
- § 242s— Centers for Disease Control and Prevention Office of Women’s Health
- § 242t— CDC surveillance and data collection for child, youth, and adult trauma
- § 242u— Improving State, local, and Tribal information sharing
- § 242v— Foreign talent recruitment programs
- § 242v–1— Securing identifiable, sensitive information and addressing other national security risks related to research
- § 242v–2— Protecting America’s biomedical research enterprise
- § 242v–3— Report on progress to address undue foreign influence
- § 243— General grant of authority for cooperation
- § 244— Public access defibrillation programs
- § 244a— Materials and resources to increase education and awareness of cardiomyopathy among school administrators, educators, and families
- § 244b— Activities relating to cardiomyopathy
- § 244c— Cardiomyopathy research
- § 244d— Promoting student access to AEDs and CPR
- § 245— Public awareness campaign on the importance of vaccinations
- § 246— Grants and services to States
- § 246a— Bureau of State Services management fund; establishment; advancements; availability
- § 247— Assisting veterans with military emergency medical training to meet requirements for becoming civilian health care professionals
- § 247a— Family support groups for Alzheimer’s disease patients
- § 247b— Project grants for preventive health services
- § 247b–1— Screenings, referrals, and education regarding lead poisoning
- § 247b–3— Education, technology assessment, and epidemiology regarding lead poisoning
- § 247b–3a— Training and reports by the Health Resources and Services Administration
- § 247b–4— National Center on Birth Defects and Developmental Disabilities
- § 247b–4a— Early detection, diagnosis, and interventions for newborns and infants with hearing loss
- § 247b–4f— Research relating to preterm labor and delivery and the care, treatment, and outcomes of preterm and low birthweight infants
- § 247b–5— Preventive health measures with respect to prostate cancer
- § 247b–6— National strategy for combating and eliminating tuberculosis
- § 247b–7— Loan repayment program
- § 247b–8— Fellowship and training programs
- § 247b–9— Diabetes in children and youth
- § 247b–9a— Better diabetes care
- § 247b–10— Compilation of data on asthma
- § 247b–11— Effects of folic acid in prevention of birth defects
- § 247b–12— Safe motherhood
- § 247b–13— Prenatal and postnatal health
- § 247b–13a— Screening and treatment for maternal mental health and substance use disorders
- § 247b–14— Oral health promotion and disease prevention
- § 247b–14a— Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment
- § 247b–15— Surveillance and education regarding infections associated with illicit drug use and other risk factors
- § 247b–16— Grants for lead poisoning related activities
- § 247b–17— Human papillomavirus (Johanna’s Law)
- § 247b–18— Surveillance and research regarding muscular dystrophy
- § 247b–19— Information and education
- § 247b–20— Food safety grants
- § 247b–21— Mosquito-borne diseases; coordination grants to States; assessment and control grants to political subdivisions
- § 247b–22— Microbicide research
- § 247b–23— National strategy and regional centers of excellence in vector-borne diseases
- § 247b–24— Addressing factors related to improving health outcomes
- § 247c— Sexually transmitted diseases; prevention and control projects and programs
- § 247c–1— Infertility and sexually transmitted diseases
- § 247c–2— Data collection regarding programs under subchapter XXIV
- § 247d— Public health emergencies
- § 247d–1— Vaccine tracking and distribution
- § 247d–2— Earlier development of diagnostic tests
- § 247d–3a— Improving State and local public health security
- § 247d–3b— Partnerships for State and regional hospital preparedness to improve surge capacity
- § 247d–3c— Guidelines for regional health care emergency preparedness and response systems
- § 247d–4— Facilities and capacities of the Centers for Disease Control and Prevention
- § 247d–4a— Infectious Diseases Rapid Response Reserve Fund
- § 247d–4b— Children’s Preparedness Unit
- § 247d–5— Combating antimicrobial resistance
- § 247d–6— Public health countermeasures to a bioterrorist attack
- § 247d–6a— Authority for use of certain procedures regarding qualified countermeasure research and development activities
- § 247d–6b— Strategic National Stockpile and security countermeasure procurements
- § 247d–6d— Targeted liability protections for pandemic and epidemic products and security countermeasures
- § 247d–6e— Covered countermeasure process
- § 247d–6f— Provision of medical countermeasures to Indian programs and facilities
- § 247d–7a— Grants regarding training and education of certain health professionals
- § 247d–7b— Emergency system for advance registration of volunteer health professional
- § 247d–7c— Supplies and services in lieu of award funds
- § 247d–7d— Security for countermeasure development and production
- § 247d–7e— Biomedical Advanced Research and Development Authority
- § 247d–7f— Collaboration and coordination
- § 247d–7g— National Biodefense Science Board and working groups
- § 247d–8— Coordinated program to improve pediatric oral health
- § 247d–9— Dental education for parents of newborns
- § 247d–10— Pilot program for public health laboratories to detect fentanyl and other synthetic opioids
- § 247d–11— State All Payer Claims Databases
- § 247d–12— Coordination and collaboration regarding blood supply
- § 247e— National Hansen’s Disease Programs Center
- § 248— Control and management of hospitals; furnishing prosthetic and orthopedic devices; transfer of patients; disposal of articles produced by patients; disposal of money and effects of deceased patients; payment of burial expenses
- § 248a— Closing or transfer of hospitals; reduction of services; Congressional authorization required
- § 248b— Transfer or financial self-sufficiency of public health service hospitals and clinics
- § 249— Medical care and treatment of quarantined and detained persons
- § 250— Medical care and treatment of Federal prisoners
- § 250a— Transfer of appropriations
- § 251— Medical examination and treatment of Federal employees; medical care at remote stations
- § 252— Medical examination of aliens
- § 253— Medical services to Coast Guard, National Oceanic and Atmospheric Administration, and Public Health Service
- § 253a— Medical services to retired personnel of National Oceanic and Atmospheric Administration
- § 253b— Former Lighthouse Service employees; medical service eligibility
- § 254— Interdepartmental work
- § 254a— Sharing of medical care facilities and resources
- § 254b— Health centers
- § 254b–1— State grants to health care providers who provide services to a high percentage of medically underserved populations or other special populations
- § 254b–2— Community health centers and the National Health Service Corps Fund
- § 254c— Rural health care services outreach, rural health network development, and small health care provider quality improvement grant programs
- § 254c–1— Grants for health services for Pacific Islanders
- § 254c–1a— Grants to nurse-managed health clinics
- § 254c–1b— Rural obstetric network grants
- § 254c–2— Special diabetes programs for type I diabetes
- § 254c–3— Special diabetes programs for Indians
- § 254c–5— Epilepsy; seizure disorder
- § 254c–6— Certain services for pregnant women
- § 254c–7— Special needs adoption programs; public awareness campaign and other activities
- § 254c–8— Healthy start for infants
- § 254c–9— Establishment of program of grants
- § 254c–10— Certain requirements
- § 254c–11— Technical assistance
- § 254c–12— Definitions
- § 254c–13— Authorization of appropriations
- § 254c–14— Telehealth network and telehealth resource centers grant programs
- § 254c–16— Mental health services delivered via telehealth
- § 254c–18— Telemedicine; incentive grants regarding coordination among States
- § 254c–19— Pediatric mental health care access grants
- § 254c–20— Expanding capacity for health outcomes
- § 254c–21— Innovation for maternal health
- § 254c–22— Integrated services for pregnant and postpartum women
- § 254d— National Health Service Corps
- § 254e— Health professional shortage areas
- § 254f— Corps personnel
- § 254f–1— Priorities in assignment of Corps personnel
- § 254g— Charges for services by entities using Corps members
- § 254h— Provision of health services by Corps members
- § 254h–1— Facilitation of effective provision of Corps services
- § 254i— Annual report to Congress; contents
- § 254j— National Advisory Council on National Health Service Corps
- § 254k— Authorization of appropriations
- § 254l— National Health Service Corps Scholarship Program
- § 254l–1— National Health Service Corps Loan Repayment Program
- § 254m— Obligated service under contract
- § 254n— Private practice
- § 254o— Breach of scholarship contract or loan repayment contract
- § 254o–1— Fund regarding use of amounts recovered for contract breach to replace services lost as result of breach
- § 254p— Special loans for former Corps members to enter private practice
- § 254q— Authorization of appropriations
- § 254q–1— Grants to States for loan repayment programs
- § 254r— Grants to State Offices of Rural Health
- § 254s— Native Hawaiian Health Scholarships
- § 254t— Demonstration project
- § 254u— Public health departments
- § 254v— Clarification regarding service in schools and other community-based settings
- § 255— Home health services
- § 256— Grants to strengthen the effectiveness, efficiency, and coordination of services for the uninsured and underinsured
- § 256a— Patient navigator grants
- § 256a–1— Establishing community health teams to support the patient-centered medical home
- § 256b— Limitation on prices of drugs purchased by covered entities
- § 256c— Bulk purchases of vaccines for certain programs
- § 256d— Breast and cervical cancer information
- § 256e— Program of payments to children’s hospitals that operate graduate medical education programs
- § 256f— Designated dental health professional shortage area
- § 256g— Grants for innovative programs
- § 256g–1— Demonstration program to increase access to dental health care services
- § 256h— Program of payments to teaching health centers that operate graduate medical education programs
- § 256i— Community-based collaborative care network program
- § 262— Regulation of biological products
- § 262a— Enhanced control of dangerous biological agents and toxins
- § 263— Preparation of biological products by Service
- § 263–1— Education on biological products
- § 263a— Certification of laboratories
- § 263a–1— Assisted reproductive technology programs
- § 263a–2— Certification of embryo laboratories
- § 263a–3— Accreditation organizations
- § 263a–4— Certification revocation and suspension
- § 263a–5— Publication
- § 263a–6— Fees
- § 263a–7— Definitions
- § 263b— Certification of mammography facilities
- § 264— Regulations to control communicable diseases
- § 265— Suspension of entries and imports from designated places to prevent spread of communicable diseases
- § 266— Special quarantine powers in time of war
- § 267— Quarantine stations, grounds, and anchorages
- § 268— Quarantine duties of consular and other officers
- § 269— Bills of health
- § 270— Quarantine regulations governing civil air navigation and civil aircraft
- § 271— Penalties for violation of quarantine laws
- § 272— Administration of oaths by quarantine officers
- § 273— Organ procurement organizations
- § 273a— National living donor mechanisms
- § 273b— Report on the long-term health effects of living organ donation
- § 274— Organ procurement and transplantation network
- § 274a— Scientific registry
- § 274b— General provisions respecting grants and contracts
- § 274c— Administration
- § 274d— Report
- § 274e— Prohibition of organ purchases
- § 274f— Reimbursement of travel and subsistence expenses incurred toward living organ donation
- § 274f–1— Public awareness; studies and demonstrations
- § 274f–2— Grants regarding hospital organ donation coordinators
- § 274f–3— Studies relating to organ donation and the recovery, preservation, and transportation of organs
- § 274f–4— Report relating to organ donation and the recovery, preservation, and transportation of organs
- § 274f–5— Criteria, standards, and regulations with respect to organs infected with HIV
- § 274g— Authorization of appropriations
- § 274i— Eligibility requirements for Stephanie Tubbs Jones Gift of Life Medal
- § 274i–1— Solicitation of donations; prohibition on use of Federal funds
- § 274i–2— Design and production of medal
- § 274i–3— Medals not treated as valuable consideration
- § 274i–4— Definitions
- § 274k— National Program
- § 274l— Stem cell therapeutic outcomes database
- § 274l–1— Definitions
- § 274m— Authorization of appropriations
- § 280b— Research
- § 280b–0— Prevention and control activities
- § 280b–1— Preventing overdoses of controlled substances
- § 280b–1a— Interpersonal violence within families and among acquaintances
- § 280b–1b— Use of allotments for rape prevention education
- § 280b–1c— Prevention of traumatic brain injury
- § 280b–1d— National program for traumatic brain injury surveillance and registries
- § 280b–1f— Prevention of falls among older adults
- § 280b–2— General provisions
- § 280b–3— Authorization of appropriations
- § 280b–4— Study conducted by the Centers for Disease Control and Prevention
- § 280c— Establishment of program
- § 280c–1— Limitation on duration of grant and requirement of matching funds
- § 280c–2— General provisions
- § 280c–3— Cooperative agreements to States and public health departments for Alzheimer’s disease and related dementias
- § 280c–4— Promotion of public health knowledge and awareness of Alzheimer’s disease and related dementias
- § 280c–5— General provisions
- § 280c–6— Projects to improve maternal, infant, and child health
- § 280e— National program of cancer registries
- § 280e–1— Planning grants regarding registries
- § 280e–2— Technical assistance in operations of statewide cancer registries
- § 280e–3— Study in certain States to determine factors contributing to elevated breast cancer mortality rates
- § 280e–3a— National childhood cancer registry
- § 280e–4— Authorization of appropriations
- § 280e–5— Voluntary registry for firefighter cancer incidence
- § 280e–11— Establishment and duties of Foundation
- § 280f— Fetal alcohol spectrum disorders prevention, intervention, and services delivery program
- § 280f–1— Strengthening capacity and education for fetal alcohol spectrum disorders
- § 280f–2— Authorization of appropriations
- § 280g— Children’s asthma treatment grants program
- § 280g–1— Early detection, diagnosis, and treatment regarding deaf and hard-of-hearing newborns, infants, and young children
- § 280g–2— Childhood malignancies
- § 280g–3— Prescription drug monitoring program
- § 280g–4— Grants to strengthen the healthcare system’s response to domestic violence, dating violence, sexual assault, and stalking
- § 280g–4a— Understanding sexual assault care in health systems
- § 280g–4b— Expanding access to unified care
- § 280g–4c— Expanding access to forensics for victims of interpersonal violence
- § 280g–5— Public and health care provider education and support services
- § 280g–6— Chronic kidney disease initiatives
- § 280g–7— Amyotrophic lateral sclerosis registry
- § 280g–7a— Surveillance of neurological diseases
- § 280g–7b— HHS public-private partnership for rare neurodegenerative diseases
- § 280g–8— Support for patients receiving a positive diagnosis of Down syndrome or other prenatally or postnatally diagnosed conditions
- § 280g–9— Programs to improve quality of life for persons with paralysis and other physical disabilities
- § 280g–10— Community Preventive Services Task Force
- § 280g–11— Awards to support community health workers and community health
- § 280g–12— Primary Care Extension Program
- § 280g–13— National congenital heart disease research, surveillance, and awareness
- § 280g–14— National diabetes prevention program
- § 280g–15— State demonstration programs to evaluate alternatives to current medical tort litigation
- § 280g–16— Food Safety Integrated Centers of Excellence
- § 280g–17— Designation and investigation of potential cancer clusters
- § 280g–18— Maternal mental health hotline
- § 280h— Grants to promote childhood nutrition and physical activity
- § 280h–1— Applied research program
- § 280h–2— Education campaign
- § 280h–3— Health professional education and training
- § 280h–4— Grants for the establishment of school-based health centers
- § 280h–5— School-based health centers
- § 280h–6— Infant and early childhood mental health promotion, intervention, and treatment
- § 280h–7— Grants to improve trauma support services and mental health care for children and youth in educational settings
- § 280h–8— Recognizing early childhood trauma related to substance abuse
- § 280i— Developmental disabilities surveillance and research program
- § 280i–1— Autism education, early detection, and intervention
- § 280i–2— Interagency Autism Coordinating Committee
- § 280i–3— Reports to Congress
- § 280i–4— Authorization of appropriations
- § 280j— National strategy for quality improvement in health care
- § 280j–1— Collection and analysis of data for quality and resource use measures
- § 280j–2— Public reporting of performance information
- § 280j–3— Quality improvement program for hospitals with a high severity adjusted readmission rate
- § 280k— Oral healthcare prevention education campaign
- § 280k–1— Research-based dental caries disease management
- § 280k–2— Authorization of appropriations
- § 280k–3— Updating national oral healthcare surveillance activities
- § 280l— Technical assistance for employer-based wellness programs
- § 280l–1— National worksite health policies and programs study
- § 280l–2— Prioritization of evaluation by Secretary
- § 280l–3— Prohibition of Federal workplace wellness requirements
- § 280m— Young women’s breast health awareness and support of young women diagnosed with breast cancer
- § 280n— National Parkinson’s Project
- § 281— Organization of National Institutes of Health
- § 282— Director of National Institutes of Health
- § 282a— Authorization of appropriations
- § 282b— Electronic coding of grants and activities
- § 282c— Public access to funded investigators’ final manuscripts
- § 283— Triennial reports of Director of NIH
- § 283a— Annual reporting to increase interagency collaboration and coordination
- § 283a–1— Annual reporting to prevent fraud and abuse
- § 283a–2— Annual reporting regarding training of graduate students for doctoral degrees
- § 283a–3— Establishment of program regarding DES
- § 283a–4— Notification to Director of personnel removed or disciplined for harassment, bullying, retaliation, or hostile working conditions
- § 283a–5— Grant recipient requirements regarding harassment investigation and reporting
- § 283c— Office of Behavioral and Social Sciences Research
- § 283d— Children’s Vaccine Initiative
- § 283e— Plan for use of animals in research
- § 283f— Requirements regarding surveys of sexual behavior
- § 283g— Muscular dystrophy; initiative through Director of National Institutes of Health
- § 283k— Biomedical and behavioral research facilities
- § 283l— Construction of regional centers for research on primates
- § 283m— Sanctuary system for surplus chimpanzees
- § 283n— Shared Instrumentation Grant Program
- § 283o— Next generation of researchers
- § 283p— Population focused research
- § 283q— Eureka prize competitions
- § 283r— National Science Advisory Board for Biosecurity
- § 284— Directors of national research institutes
- § 284a— Advisory councils
- § 284c— Certain uses of funds
- § 284d— Definitions
- § 284e— Research on osteoporosis, Paget’s disease, and related bone disorders
- § 284f— Parkinson’s disease
- § 284g— Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
- § 284h— Pediatric Research Initiative
- § 284i— Autoimmune diseases
- § 284j— Muscular dystrophy research
- § 284k— Clinical research
- § 284l— Enhancement awards
- § 284m— Program for pediatric studies of drugs
- § 284m–1— Pediatric Advisory Committee
- § 284n— Certain demonstration projects
- § 284o— Activities of the National Institutes of Health with respect to research on paralysis
- § 284p— Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis
- § 284q— Pain research
- § 284q–1— NIH opioid research
- § 284r— Basic research
- § 284s— Tick-borne diseases
- § 285— Purpose of Institute
- § 285a— National Cancer Program
- § 285a–1— Cancer control programs
- § 285a–2— Special authorities of Director
- § 285a–3— National cancer research and demonstration centers
- § 285a–4— President’s Cancer Panel; establishment, membership, etc., functions
- § 285a–5— Associate Director for Prevention; appointment; function
- § 285a–6— Breast and gynecological cancers
- § 285a–7— Prostate cancer
- § 285a–9— Grants for education, prevention, and early detection of radiogenic cancers and diseases
- § 285a–10— Research, information, and education with respect to blood cancer
- § 285a–11— Pediatric cancer research, awareness, and survivorship
- § 285a–11a— Cancer survivorship programs
- § 285a–11b— Best practices for long-term follow-up services for pediatric cancer survivors
- § 285a–12— Interagency Breast Cancer and Environmental Research Coordinating Committee
- § 285a–13— Scientific framework for recalcitrant cancers
- § 285b— Purpose of Institute
- § 285b–1— Heart, blood vessel, lung, and blood disease prevention and control programs
- § 285b–2— Information and education
- § 285b–3— National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program; administrative provisions
- § 285b–4— National research and demonstration centers
- § 285b–6— Associate Director for Prevention; appointment; function
- § 285b–7— National Center on Sleep Disorders Research
- § 285b–7a— Heart attack, stroke, and other cardiovascular diseases in women
- § 285b–7b— Coordination of Federal asthma activities
- § 285b–7c— Tuberculosis
- § 285b–8— Congenital heart disease
- § 285b–9— HHS valvular heart disease activities
- § 285c— Purpose of Institute
- § 285c–1— Data systems and information clearinghouses
- § 285c–2— Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions
- § 285c–3— Interagency coordinating committees
- § 285c–4— Advisory boards
- § 285c–5— Research and training centers; development or expansion
- § 285c–6— Advisory council subcommittees
- § 285c–7— Biennial report
- § 285c–8— Nutritional disorders program
- § 285c–9— Juvenile diabetes
- § 285d— Purpose of Institute
- § 285d–1— National arthritis and musculoskeletal and skin diseases program
- § 285d–2— Research and training
- § 285d–3— Data system and information clearinghouse
- § 285d–4— Interagency coordinating committees
- § 285d–5— Arthritis and musculoskeletal diseases demonstration projects
- § 285d–6— Multipurpose arthritis and musculoskeletal diseases centers
- § 285d–6a— Lupus
- § 285d–7— Advisory Board
- § 285d–8— Juvenile arthritis and related conditions
- § 285e— Purpose of Institute
- § 285e–1— Special functions
- § 285e–2— Alzheimer’s Disease centers
- § 285e–3— Claude D. Pepper Older Americans Independence Centers
- § 285e–4— Awards for leadership and excellence in Alzheimer’s disease and related dementias
- § 285e–5— Research relevant to appropriate services for individuals with Alzheimer’s disease and related dementias and their families
- § 285e–6— Dissemination of research results
- § 285e–7— Clearinghouse on Alzheimer’s Disease
- § 285e–8— Dissemination project
- § 285e–9— Alzheimer’s disease registry
- § 285e–10— Aging processes regarding women
- § 285e–10a— Alzheimer’s clinical research and training awards
- § 285f— Purpose of Institute
- § 285f–1— Research centers regarding chronic fatigue syndrome
- § 285f–2— Research and research training regarding tuberculosis
- § 285f–3— Sexually transmitted disease clinical research and training awards
- § 285f–4— Microbicide research and development
- § 285f–5— Research centers for pathogens of pandemic concern
- § 285g— Purpose of Institute
- § 285g–1— Sudden infant death syndrome research
- § 285g–2— Research on intellectual disabilities
- § 285g–3— Associate Director for Prevention; appointment; function
- § 285g–4— National Center for Medical Rehabilitation Research
- § 285g–5— Research centers with respect to contraception and infertility
- § 285g–6— Program regarding obstetrics and gynecology
- § 285g–7— Child health research centers
- § 285g–8— Prospective longitudinal study on adolescent health
- § 285g–9— Fragile X
- § 285g–10— Investment in tomorrow’s pediatric researchers
- § 285g–11— Research on the health and development effects of media and related technology on infants, children, and adolescents
- § 285h— Purpose of Institute
- § 285i— Purpose of Institute
- § 285i–1— Clinical research on eye care and diabetes
- § 285j— Purpose of Institute
- § 285j–1— Spinal cord regeneration research
- § 285j–2— Bioengineering research
- § 285j–3— Research on multiple sclerosis
- § 285k— National Institute of General Medical Sciences
- § 285l— Purpose of Institute
- § 285l–1— Applied Toxicological Research and Testing Program
- § 285l–2— Definitions
- § 285l–3— Interagency Coordinating Committee on the Validation of Alternative Methods
- § 285l–4— Federal agency action
- § 285l–5— Application
- § 285l–6— Methods of controlling certain insect and vermin populations
- § 285m— Purpose of Institute
- § 285m–1— National Deafness and Other Communication Disorders Program
- § 285m–2— Data System and Information Clearinghouse
- § 285m–3— Multipurpose deafness and other communication disorders center
- § 285m–4— National Institute on Deafness and Other Communication Disorders Advisory Board
- § 285m–5— Interagency Coordinating Committee
- § 285m–6— Limitation on administrative expenses
- § 285n— Purpose of Institute
- § 285n–1— Associate Director for Prevention
- § 285n–2— National Alcohol Research Centers; mandatory grant for research of effects of alcohol on elderly
- § 285o— Purpose of Institute
- § 285o–1— Associate Director for Prevention
- § 285o–2— Drug Abuse Research Centers
- § 285o–3— Office on AIDS
- § 285o–4— Medication Development Program
- § 285p— Purpose of Institute
- § 285p–1— Associate Director for Prevention
- § 285p–2— Office of Rural Mental Health Research
- § 285p–3— Office on AIDS
- § 285q— Purpose of Institute
- § 285q–1— Specific authorities
- § 285q–2— Advisory council
- § 285r— Purpose of the Institute
- § 285s— Purpose of Institute
- § 285t— Purpose of Institute
- § 285t–1— Centers of excellence for research education and training
- § 285t–3— General provisions regarding the Institute
- § 286— National Library of Medicine
- § 286a— Board of Regents
- § 286a–1— Library facilities
- § 286b–1— Definitions
- § 286b–2— National Medical Libraries Assistance Advisory Board
- § 286b–3— Grants for training in medical library sciences
- § 286b–4— Assistance for projects in sciences related to health, for research and development in medical library science, and for development of education technologies
- § 286b–5— Grants for establishing, expanding, and improving basic resources of medical libraries and related instrumentalities
- § 286b–6— Grants and contracts for establishment of regional medical libraries
- § 286b–7— Financial support of biomedical scientific publications
- § 286b–8— Grant payments, records, and audit
- § 286c— Purpose, establishment, functions, and funding of National Center for Biotechnology Information
- § 286d— National Information Center
- § 287— National Center for Advancing Translational Sciences
- § 287a— Cures Acceleration Network
- § 287a–1— Office of Rare Diseases
- § 287a–2— Rare disease regional centers of excellence
- § 287a–4— General clinical research centers
- § 287b— General purpose
- § 287c–11— Dietary supplements
- § 287c–21— Purpose of Center
- § 287d— Office of Research on Women’s Health
- § 287d–1— National data system and clearinghouse on research on women’s health
- § 287d–2— Biennial report
- § 288— Ruth L. Kirschstein National Research Service Awards
- § 288–1— Intramural loan repayment program
- § 288–2— Extramural loan repayment program
- § 288–4— Undergraduate scholarship program regarding professions needed by National Research Institutes
- § 288a— Visiting Scientist Awards
- § 288b— Studies respecting biomedical and behavioral research personnel
- § 289— Institutional review boards; ethics guidance program
- § 289a— Peer review requirements
- § 289a–1— Certain provisions regarding review and approval of proposals for research
- § 289a–2— Inclusion of women and minorities in clinical research
- § 289b— Office of Research Integrity
- § 289b–1— Protection against financial conflicts of interest in certain projects of research
- § 289c— Research on public health emergencies
- § 289c–1— Collaborative use of certain health services research funds
- § 289d— Animals in research
- § 289e— Use of appropriations
- § 289f— Gifts and donations; memorials
- § 289g— Fetal research
- § 289g–1— Research on transplantation of fetal tissue
- § 289g–2— Prohibitions regarding human fetal tissue
- § 289g–3— Breast implant research
- § 289g–4— Support for emergency medicine research
- § 289g–5— Precision medicine initiative
- § 290— National Institutes of Health Management Fund; establishment; advancements; availability; final adjustments of advances
- § 290a— Victims of fire
- § 290b— Establishment and duties of Foundation
- § 290c— Advanced Research Projects Agency–Health
- § 290aa— Substance Abuse and Mental Health Services Administration
- § 290aa–0— National Mental Health and Substance Use Policy Laboratory
- § 290aa–0a— Behavioral health crisis coordinating office
- § 290aa–0b— Interdepartmental Serious Mental Illness Coordinating Committee
- § 290aa–1— Advisory councils
- § 290aa–2a— Report on individuals with co-occurring mental illness and substance abuse disorders
- § 290aa–3— Peer review
- § 290aa–4— Center for behavioral health statistics and quality
- § 290aa–5— Grants for the benefit of homeless individuals
- § 290aa–5a— Behavioral health and substance use disorder resources for Native Americans
- § 290aa–15— Department of Health and Human Services grant accountability
- § 290aa–16— Evaluation of performance of Department of Health and Human Services programs
- § 290aa–17— Assisted outpatient treatment grant program for individuals with serious mental illness
- § 290aa–18— Limitations on authority
- § 290bb— Center for Substance Abuse Treatment
- § 290bb–1— Residential treatment programs for pregnant and postpartum women
- § 290bb–2— Priority substance use disorder treatment needs of regional and national significance
- § 290bb–2a— Medical treatment of narcotics addiction; report to Congress
- § 290bb–6— Action by Center for Substance Abuse Treatment and States concerning military facilities
- § 290bb–7— Substance use disorder treatment and early intervention services for children, adolescents, and young adults
- § 290bb–7a— Youth prevention and recovery
- § 290bb–10— Evidence-based prescription opioid and heroin treatment and interventions demonstration
- § 290bb–11— Building capacity for family-focused residential treatment
- § 290bb–21— Center for Substance Abuse Prevention
- § 290bb–22— Priority substance use disorder prevention needs of regional and national significance
- § 290bb–25— Grants for services for children of substance abusers
- § 290bb–25b— Programs to reduce underage drinking
- § 290bb–25d— Centers of excellence on services for individuals with fetal alcohol syndrome and alcohol-related birth defects and treatment for individuals with such conditions and their families
- § 290bb–25f— Prevention and education programs
- § 290bb–25g— Awareness campaigns
- § 290bb–31— Center for Mental Health Services
- § 290bb–32— Priority mental health needs of regional and national significance
- § 290bb–33— Student suicide awareness and prevention training
- § 290bb–34— Suicide prevention technical assistance center
- § 290bb–36— Youth suicide early intervention and prevention strategies
- § 290bb–36a— Suicide prevention for youth
- § 290bb–36b— Mental health and substance use disorder services for students in higher education
- § 290bb–36c— National Suicide Prevention Lifeline program
- § 290bb–36d— Treatment Referral Routing Service
- § 290bb–37— Mental health crisis response partnership pilot program
- § 290bb–38— Grants for jail diversion programs
- § 290bb–39— Peer-supported mental health services
- § 290bb–39a— Best practices for behavioral and mental health intervention teams
- § 290bb–40— Grants for the integrated treatment of serious mental illness and co-occurring substance abuse
- § 290bb–41— Mental health awareness training grants
- § 290bb–42— Improving uptake and patient access to integrated care services
- § 290bb–43— Adult suicide prevention
- § 290bb–44— Assertive community treatment grant program
- § 290bb–45— Center of Excellence for Eating Disorders for education and training on eating disorders
- § 290cc–21— Formula grants to States
- § 290cc–22— Purpose of grants
- § 290cc–23— Requirement of matching funds
- § 290cc–24— Determination of amount of allotment
- § 290cc–25— Conversion to categorical program in event of failure of State regarding expenditure of grants
- § 290cc–26— Provision of certain information from State
- § 290cc–27— Description of intended expenditures of grant
- § 290cc–28— Requirement of reports by States
- § 290cc–29— Requirement of application
- § 290cc–30— Technical assistance
- § 290cc–31— Failure to comply with agreements
- § 290cc–32— Prohibition against certain false statements
- § 290cc–33— Nondiscrimination
- § 290cc–34— Definitions
- § 290cc–35— Funding
- § 290dd— Substance abuse among government and other employees
- § 290dd–1— Admission of substance abusers to private and public hospitals and outpatient facilities
- § 290dd–2— Confidentiality of records
- § 290dd–2a— Promoting access to information on evidence-based programs and practices
- § 290dd–3— Grants for reducing overdose deaths
- § 290dd–4— Program to support coordination and continuation of care for drug overdose patients
- § 290ee— Opioid overdose reversal medication access, education, and co-prescribing grant programs
- § 290ee–1— First responder training
- § 290ee–2— Building communities of recovery
- § 290ee–2a— Peer support technical assistance center
- § 290ee–3— State demonstration grants for comprehensive opioid abuse response
- § 290ee–3a— Grant program for State and Tribal response to opioid use disorders
- § 290ee–4— Mental and behavioral health outreach and education at institutions of higher education
- § 290ee–5— National recovery housing best practices
- § 290ee–5a— Sobriety treatment and recovery teams
- § 290ee–6— Regional Centers of Excellence in Substance Use Disorder Education
- § 290ee–7— Comprehensive opioid recovery centers
- § 290ee–8— Career Act; treatment, recovery, and workforce support grants
- § 290ee–9— Services for families and patients in crisis
- § 290ee–10— Rural emergency medical service training and equipment assistance program
- § 290ff— Comprehensive community mental health services for children with serious emotional disturbances
- § 290ff–1— Requirements with respect to carrying out purpose of grants
- § 290ff–2— Individualized plan for services
- § 290ff–3— Additional provisions
- § 290ff–4— General provisions
- § 290hh— Children and violence
- § 290hh–1— Grants to address the problems of persons who experience traumatic events
- § 290ii— Requirement relating to the rights of residents of certain facilities
- § 290ii–1— Reporting requirement
- § 290ii–2— Regulations and enforcement
- § 290jj— Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth
- § 290jj–1— Reporting requirement
- § 290jj–2— Regulations and enforcement
- § 290kk— Applicability to designated programs
- § 290kk–1— Religious organizations as program participants
- § 290kk–2— Limitations on use of funds for certain purposes
- § 290kk–3— Educational requirements for personnel in drug treatment programs
- § 290ll— Fellowships
- § 291— Congressional declaration of purpose
- § 291a— Authorization of appropriations
- § 291b— State allotments
- § 291c— General regulations
- § 291d— State plans
- § 291e— Projects for construction or modernization
- § 291f— Payments for construction or modernization
- § 291g— Withholding of payments; noncompliance with requirements
- § 291h— Judicial review
- § 291i— Recovery of expenditures under certain conditions
- § 291j— Loans
- § 291j–1— Loan guarantees and loans
- § 291j–2— Allocation among States
- § 291j–3— Applications and conditions
- § 291j–4— Payment of interest on guaranteed loans
- § 291j–5— Limitation on amounts of loans guaranteed or directly made
- § 291j–6— Loan guarantee and loan fund
- § 291j–7— Loans to public facilities
- § 291j–8— Authorization of appropriations
- § 291j–9— Eligibility for grants
- § 291j–10— Payments
- § 291k— Federal Hospital Council
- § 291l— Conference of State agencies
- § 291m— State control of operations
- § 291m–1— Loans for certain hospital experimentation projects
- § 291o— Definitions
- § 291o–1— Financial statements
- § 292— Statement of purpose
- § 292a— Scope and duration of loan insurance program
- § 292b— Limitations on individual insured loans and on loan insurance
- § 292c— Sources of funds
- § 292d— Eligibility of borrowers and terms of insured loans
- § 292e— Certificate of loan insurance; effective date of insurance
- § 292f— Default of borrower
- § 292g— Risk-based premiums
- § 292h— Office for Health Education Assistance Loan Default Reduction
- § 292i— Insurance account
- § 292j— Powers and responsibilities of Secretary
- § 292k— Participation by Federal credit unions in Federal, State, and private student loan insurance programs
- § 292l— Determination of eligible students
- § 292m— Repayment by Secretary of loans of deceased or disabled borrowers
- § 292n— Additional requirements for institutions and lenders
- § 292o— Definitions
- § 292p— Authorization of appropriations
- § 292q— Agreements for operation of school loan funds
- § 292r— Loan provisions
- § 292s— Medical schools and primary health care
- § 292t— Individuals from disadvantaged backgrounds
- § 292u— Administrative provisions
- § 292v— Provision by schools of information to students
- § 292w— Procedures for appeal of termination of agreements
- § 292x— Distribution of assets from loan funds
- § 292y— General provisions
- § 293— Centers of excellence
- § 293a— Scholarships for disadvantaged students
- § 293b— Loan repayments and fellowships regarding faculty positions
- § 293c— Educational assistance in the health professions regarding individuals from disadvantaged backgrounds
- § 293d— Authorization of appropriation
- § 293e— Grants for health professions education
- § 293k— Primary care training and enhancement
- § 293k–1— Training opportunities for direct care workers
- § 293k–2— Training in general, pediatric, and public health dentistry
- § 293l— Advisory Committee on Training in Primary Care Medicine and Dentistry
- § 293l–1— Teaching health centers development grants
- § 293m— Rural physician training grants
- § 294— General provisions
- § 294a— Area health education centers
- § 294b— Continuing educational support for health professionals serving in rural and underserved communities
- § 294c— Education and training relating to geriatrics
- § 294d— Quentin N. Burdick program for rural interdisciplinary training
- § 294e— Allied health and other disciplines
- § 294e–1— Mental and behavioral health education and training grants
- § 294f— Advisory Committee on Interdisciplinary, Community-Based Linkages
- § 294i— Program for education and training in pain care
- § 294i–1— Emergency department alternatives to opioids program
- § 294j— Demonstration program to integrate quality improvement and patient safety training into clinical education of health professionals
- § 294k— Training demonstration program
- § 294n— Health professions workforce information and analysis
- § 294o— Advisory Council on Graduate Medical Education
- § 294p— Training for health care providers
- § 294q— National Health Care Workforce Commission
- § 294r— State health care workforce development grants
- § 294s— Rural maternal and obstetric care training demonstration
- § 294t— Programs to promote mental health among the health professional workforce
- § 294u— Education and awareness initiative encouraging use of mental health and substance use disorder services by health care professionals
- § 295— General provisions
- § 295a— Public health training centers
- § 295b— Public health traineeships
- § 295c— Preventive medicine and public health training grant program
- § 295d— Health administration traineeships and special projects
- § 295e— Authorization of appropriations
- § 295f— Investment in tomorrow’s pediatric health care workforce
- § 295f–1— Public Health Workforce Loan Repayment Program
- § 295f–2— Training for mid-career public and allied health professionals
- § 295f–3— Fellowship training in applied public health epidemiology, public health laboratory science, public health informatics, and expansion of the Epidemic Intelligence Service
- § 295h— Loan repayment program for substance use disorder treatment workforce
- § 295j— Preferences and required information in certain programs
- § 295k— Health professions data
- § 295m— Prohibition against discrimination on basis of sex
- § 295n–1— Application
- § 295n–2— Use of funds
- § 295o— Matching requirement
- § 295o–1— Generally applicable provisions
- § 295o–2— Technical assistance
- § 295p— Definitions
- § 296— Definitions
- § 296a— Application
- § 296b— Use of funds
- § 296c— Matching requirement
- § 296d— Preference
- § 296e— Generally applicable provisions
- § 296e–1— Grants for health professions education
- § 296f— Technical assistance
- § 296g— Prohibition against discrimination by schools on basis of sex
- § 296j— Advanced education nursing grants
- § 296j–1— Demonstration grants for family nurse practitioner training programs
- § 296m— Workforce diversity grants
- § 296p— Nurse education, practice, quality, and retention grants
- § 297a— Student loan fund
- § 297b— Loan provisions
- § 297d— Allotments and payments of Federal capital contributions
- § 297e— Distribution of assets from loan funds
- § 297g— Modification of agreements; compromise, waiver or release
- § 297i— Procedures for appeal of terminations
- § 297n— Loan repayment and scholarship programs
- § 297n–1— Nurse faculty loan program
- § 297o— Eligible individual student loan repayment
- § 297t— National Advisory Council on Nurse Education and Practice
- § 298— Comprehensive geriatric education
- § 298d— Authorization of appropriations
- § 299— Mission and duties
- § 299a— General authorities
- § 299a–1— Research on health disparities
- § 299b— Health care outcome improvement research
- § 299b–1— Private-public partnerships to improve organization and delivery
- § 299b–2— Information on quality and cost of care
- § 299b–3— Information systems for health care improvement
- § 299b–4— Research supporting primary care and access in underserved areas
- § 299b–4a— Studies on preventive interventions in primary care for older Americans
- § 299b–5— Health care practice and technology innovation
- § 299b–6— Coordination of Federal Government quality improvement efforts
- § 299b–7— Research on outcomes of health care items and services
- § 299b–21— Definitions
- § 299b–22— Privilege and confidentiality protections
- § 299b–23— Network of patient safety databases
- § 299b–24— Patient safety organization certification and listing
- § 299b–24a— Activities regarding women’s health
- § 299b–25— Technical assistance
- § 299b–26— Severability
- § 299b–31— Quality measure development
- § 299b–33— Health care delivery system research
- § 299b–34— Quality improvement technical assistance and implementation
- § 299b–35— Grants or contracts to implement medication management services in treatment of chronic diseases
- § 299b–36— Program to facilitate shared decisionmaking
- § 299b–37— Dissemination and building capacity for research
- § 299c— Advisory Council for Healthcare Research and Quality
- § 299c–1— Peer review with respect to grants and contracts
- § 299c–2— Certain provisions with respect to development, collection, and dissemination of data
- § 299c–3— Dissemination of information
- § 299c–4— Additional provisions with respect to grants and contracts
- § 299c–5— Certain administrative authorities
- § 299c–6— Funding
- § 299c–7— Definitions
- § 300— Project grants and contracts for family planning services
- § 300a— Formula grants to States for family planning services
- § 300a–1— Training grants and contracts; authorization of appropriations
- § 300a–2— Conduct, etc., of research activities
- § 300a–3— Informational and educational materials development grants and contracts; authorization of appropriations
- § 300a–4— Grants and contracts
- § 300a–5— Voluntary participation by individuals; participation not prerequisite for eligibility or receipt of other services and information
- § 300a–6— Prohibition against funding programs using abortion as family planning method
- § 300a–7— Sterilization or abortion
- § 300a–8— Penalty for United States, etc., officer or employee coercing or endeavoring to coerce procedure upon beneficiary of Federal program
- § 300b–1— Research project grants and contracts
- § 300b–2— Voluntary participation by individuals
- § 300b–3— Application; special consideration to prior sickle cell anemia grant recipients
- § 300b–4— Public Health Service facilities
- § 300b–5— Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment
- § 300b–6— Applied technology
- § 300b–7— Tourette Syndrome
- § 300b–8— Improved newborn and child screening for heritable disorders
- § 300b–9— Evaluating the effectiveness of newborn and child screening and followup programs
- § 300b–10— Advisory Committee on Heritable Disorders in Newborns and Children
- § 300b–11— Clearinghouse of newborn screening information
- § 300b–12— Laboratory quality and surveillance
- § 300b–13— Interagency Coordinating Committee on Newborn and Child Screening
- § 300b–14— National contingency plan for newborn screening
- § 300b–15— Hunter Kelly Research Program
- § 300b–16— Authorization of appropriations for newborn screening programs and activities
- § 300b–17— Report by Secretary
- § 300c–11— Addressing sudden unexpected infant death and sudden unexpected death in childhood
- § 300c–12— Sudden infant death syndrome research
- § 300c–13— Continuing activities related to stillbirth, sudden unexpected infant death and sudden unexplained death in childhood
- § 300c–14— Report to Congress
- § 300c–22— Blood-separation centers
- § 300d— Establishment
- § 300d–3— Grants to improve trauma care in rural areas
- § 300d–4— Emergency medical services
- § 300d–5— Competitive grants for trauma systems for the improvement of trauma care
- § 300d–6— Competitive grants for trauma centers
- § 300d–11— Establishment of program
- § 300d–12— Requirement of matching funds for fiscal years subsequent to first fiscal year of payments
- § 300d–13— Requirements with respect to carrying out purpose of allotments
- § 300d–14— Requirement of submission to Secretary of trauma plan and certain information
- § 300d–15— Restrictions on use of payments
- § 300d–17— Requirement of submission of application containing certain agreements and assurances
- § 300d–18— Determination of amount of allotment
- § 300d–19— Failure to comply with agreements
- § 300d–20— Prohibition against certain false statements
- § 300d–21— Technical assistance and provision by Secretary of supplies and services in lieu of grant funds
- § 300d–22— Report by Secretary
- § 300d–31— Definitions
- § 300d–32— Funding
- § 300d–41— Grants for certain trauma centers
- § 300d–42— Preferences in making grants
- § 300d–43— Certain agreements
- § 300d–44— General provisions
- § 300d–45— Authorization of appropriations
- § 300d–46— Definition
- § 300d–51— Residency training programs in emergency medicine
- § 300d–52— State grants for projects regarding traumatic brain injury
- § 300d–53— State grants for protection and advocacy services
- § 300d–54— Stop, Observe, Ask, and Respond to Health and Wellness Training Program
- § 300d–61— Establishment of Program
- § 300d–71— Maintenance of the national toll-free number and other communication capabilities
- § 300d–72— Promoting poison control center utilization
- § 300d–73— Maintenance of the poison control center grant program
- § 300d–74— Rule of construction
- § 300d–81— Grants to States
- § 300d–82— Authorization of appropriations
- § 300d–91— Military and civilian partnership for trauma readiness grant program
- § 300e— Requirements of health maintenance organizations
- § 300e–1— Definitions
- § 300e–4— Loans and loan guarantees for initial operation costs
- § 300e–5— Application requirements
- § 300e–6— Administration of assistance programs
- § 300e–7— General provisions relating to loan guarantees and loans
- § 300e–8— Authorization of appropriations
- § 300e–9— Employees’ health benefits plans
- § 300e–10— Restrictive State laws and practices
- § 300e–11— Continued regulation of health maintenance organizations
- § 300e–12— Limitation on source of funding for health maintenance organizations
- § 300e–14— Annual report
- § 300e–14a— Health services for Indians and domestic agricultural migratory and seasonal workers
- § 300e–16— Training and technical assistance
- § 300e–17— Financial disclosure
- § 300f— Definitions
- § 300g— Coverage
- § 300g–1— National drinking water regulations
- § 300g–2— State primary enforcement responsibility
- § 300g–3— Enforcement of drinking water regulations
- § 300g–4— Variances
- § 300g–5— Exemptions
- § 300g–6— Prohibition on use of lead pipes, solder, and flux
- § 300g–7— Monitoring of contaminants
- § 300g–8— Operator certification
- § 300g–9— Capacity development
- § 300g–10— Cybersecurity support for public water systems
- § 300h— Regulations for State programs
- § 300h–1— State primary enforcement responsibility
- § 300h–2— Enforcement of program
- § 300h–3— Interim regulation of underground injections
- § 300h–4— Optional demonstration by States relating to oil or natural gas
- § 300h–5— Regulation of State programs
- § 300h–6— Sole source aquifer demonstration program
- § 300h–7— State programs to establish wellhead protection areas
- § 300h–8— State ground water protection grants
- § 300h–9— Secure geologic storage permitting
- § 300i— Emergency powers
- § 300i–1— Tampering with public water systems
- § 300i–2— Community water system risk and resilience
- § 300i–3— Contaminant prevention, detection and response
- § 300i–4— Supply disruption prevention, detection and response
- § 300j— Assurances of availability of adequate supplies of chemicals necessary for treatment of water
- § 300j–1— Research, technical assistance, information, training of personnel
- § 300j–1a— Innovative water technology grant program
- § 300j–2— Grants for State programs
- § 300j–3— Special project grants and guaranteed loans
- § 300j–3a— Grants to public sector agencies
- § 300j–3b— Contaminant standards or treatment technique guidelines
- § 300j–3c— National assistance program for water infrastructure and watersheds
- § 300j–3d— Water supply cost savings
- § 300j–4— Records and inspections
- § 300j–5— National Drinking Water Advisory Council
- § 300j–6— Federal agencies
- § 300j–7— Judicial review
- § 300j–8— Citizen’s civil action
- § 300j–9— General provisions
- § 300j–10— Appointment of scientific, etc., personnel by Administrator of Environmental Protection Agency for implementation of responsibilities; compensation
- § 300j–11— Indian Tribes
- § 300j–12— State revolving loan funds
- § 300j–13— Source water quality assessment
- § 300j–14— Source water petition program
- § 300j–15— Water conservation plan
- § 300j–16— Assistance to colonias
- § 300j–17— Estrogenic substances screening program
- § 300j–18— Drinking water studies
- § 300j–18a— Annual study on boil water advisories
- § 300j–19— Algal toxin risk assessment and management
- § 300j–19a— Assistance for small and disadvantaged communities
- § 300j–19b— Reducing lead in drinking water
- § 300j–19c— Study on intractable water systems
- § 300j–19d— Review of technologies
- § 300j–19e— Water infrastructure and workforce investment
- § 300j–19f— Operational sustainability of small public water systems
- § 300j–19g— Midsize and Large Drinking Water System Infrastructure Resilience and Sustainability Program
- § 300j–19h— Advanced drinking water technologies
- § 300j–21— Definitions
- § 300j–22— Recall of drinking water coolers with lead-lined tanks
- § 300j–23— Drinking water coolers containing lead
- § 300j–24— Lead contamination in school drinking water
- § 300j–25— Drinking water fountain replacement for schools
- § 300j–26— Certification of testing laboratories
- § 300j–27— Registry for lead exposure and Advisory Committee
- § 300k— Establishment of program of grants to States
- § 300l— Requirement of matching funds
- § 300l–1— Requirement regarding medicaid
- § 300m— Requirements with respect to type and quality of services
- § 300n— Additional required agreements
- § 300n–1— Description of intended uses of grant
- § 300n–2— Requirement of submission of application
- § 300n–3— Technical assistance and provision of supplies and services in lieu of grant funds
- § 300n–4— Evaluations and reports
- § 300n–4a— Supplemental grants for additional preventive health services
- § 300n–5— Funding for general program
- § 300q— Loan and loan guarantee authority
- § 300q–2— General provisions
- § 300r— Grants for construction or modernization projects
- § 300s— General regulations
- § 300s–1— Medical facility project applications
- § 300s–1a— Recovery of expenditures under certain conditions
- § 300s–2— State supervision or control of operations of facilities receiving funds
- § 300s–3— Definitions
- § 300s–4— Reporting and audit requirements for recipients
- § 300s–5— Availability of technical and other nonfinancial assistance to eligible applicants
- § 300s–6— Enforcement of assurances
- § 300t— Development grants for health systems agencies
- § 300t–11— Grants and assistance for establishment of program
- § 300t–12— Grants for discontinuance and conversion
- § 300t–13— Grants to States for reduction of excess hospital capacity
- § 300t–14— Authorization of appropriations
- § 300u— General authority of Secretary
- § 300u–1— Grants and contracts for research programs; authority of Secretary; review of applications; additional functions; periodic public survey
- § 300u–2— Grants and contracts for community health programs
- § 300u–3— Grants and contracts for information programs; authority of Secretary; particular activities
- § 300u–4— Status reports to President and Congress; study of health education and preventive health services with respect to insurance coverage
- § 300u–5— Centers for research and demonstration of health promotion and disease prevention
- § 300u–6— Office of Minority Health
- § 300u–6a— Individual offices of minority health within the Department
- § 300u–7— Office of Adolescent Health
- § 300u–8— Biennial report regarding nutrition and health
- § 300u–9— Education regarding DES
- § 300u–10— National Prevention, Health Promotion and Public Health Council
- § 300u–11— Prevention and Public Health Fund
- § 300u–12— Education and outreach campaign regarding preventive benefits
- § 300u–13— Community transformation grants
- § 300u–14— Healthy aging, living well; evaluation of community-based prevention and wellness programs for Medicare beneficiaries
- § 300u–15— Research on optimizing the delivery of public health services
- § 300u–16— Establishment of substance use disorder information dashboard
- § 300w— Authorization of appropriations
- § 300w–1— Allotments
- § 300w–2— Payments under allotments to States
- § 300w–3— Use of allotments
- § 300w–4— Application for payments; State plan
- § 300w–5— Reports, data, and audits
- § 300w–6— Withholding of funds
- § 300w–7— Nondiscrimination provisions
- § 300w–8— Criminal penalty for false statements
- § 300w–9— Emergency medical services for children
- § 300x— Formula grants to States
- § 300x–1— State plan for comprehensive community mental health services for certain individuals
- § 300x–2— Certain agreements
- § 300x–3— State mental health planning council
- § 300x–4— Additional provisions
- § 300x–5— Restrictions on use of payments
- § 300x–6— Application for grant
- § 300x–7— Determination of amount of allotment
- § 300x–8— Definitions
- § 300x–9— Funding
- § 300x–21— Formula grants to States
- § 300x–22— Certain allocations
- § 300x–23— Intravenous substance use
- § 300x–24— Requirements regarding tuberculosis and human immunodeficiency virus
- § 300x–25— Group homes for persons in recovery from substance use disorders
- § 300x–26— Sale of tobacco products to individuals under age of 21
- § 300x–27— Treatment services for pregnant women
- § 300x–28— Additional agreements
- § 300x–30— Maintenance of effort regarding State expenditures
- § 300x–31— Restrictions on expenditure of grant
- § 300x–32— Application for grant; approval of State plan
- § 300x–33— Determination of amount of allotment
- § 300x–34— Definitions
- § 300x–35— Funding
- § 300x–51— Opportunity for public comment on State plans
- § 300x–52— Requirement of reports and audits by States
- § 300x–53— Additional requirements
- § 300x–54— Disposition of certain funds appropriated for allotments
- § 300x–55— Failure to comply with agreements
- § 300x–56— Prohibitions regarding receipt of funds
- § 300x–57— Nondiscrimination
- § 300x–58— Technical assistance and provision of supplies and services in lieu of grant funds
- § 300x–59— Plans for performance partnerships
- § 300x–60— Rule of construction regarding delegation of authority to States
- § 300x–61— Solicitation of views of certain entities
- § 300x–62— Availability to States of grant payments
- § 300x–63— Continuation of certain programs
- § 300x–64— Definitions
- § 300x–65— Services provided by nongovernmental organizations
- § 300x–66— Services for individuals with co-occurring disorders
- § 300x–67— Public health emergencies
- § 300x–68— Joint applications
- § 300y— Data infrastructure development
- § 300y–11— Interim maintenance treatment
- § 300z— Findings and purposes
- § 300z–1— Definitions; regulations applicable
- § 300z–2— Demonstration projects; grant authorization, etc.
- § 300z–3— Uses of grants for demonstration projects for services
- § 300z–4— Grants for demonstration projects for services
- § 300z–5— Requirements for applications
- § 300z–6— Coordination of programs
- § 300z–7— Research
- § 300z–8— Evaluation and administration
- § 300z–9— Authorization of appropriations
- § 300z–10— Restrictions
- § 300aa–1— Establishment
- § 300aa–2— Program responsibilities
- § 300aa–3— Plan
- § 300aa–5— National Vaccine Advisory Committee
- § 300aa–6— Authorization of appropriations
- § 300aa–10— Establishment of program
- § 300aa–11— Petitions for compensation
- § 300aa–12— Court jurisdiction
- § 300aa–13— Determination of eligibility and compensation
- § 300aa–14— Vaccine Injury Table
- § 300aa–15— Compensation
- § 300aa–16— Limitations of actions
- § 300aa–17— Subrogation
- § 300aa–19— Advisory Commission on Childhood Vaccines
- § 300aa–21— Authority to bring actions
- § 300aa–22— Standards of responsibility
- § 300aa–23— Trial
- § 300aa–25— Recording and reporting of information
- § 300aa–26— Vaccine information
- § 300aa–27— Mandate for safer childhood vaccines
- § 300aa–28— Manufacturer recordkeeping and reporting
- § 300aa–31— Citizen’s actions
- § 300aa–32— Judicial review
- § 300aa–33— Definitions
- § 300aa–34— Termination of program
- § 300bb–1— State and local governmental group health plans must provide continuation coverage to certain individuals
- § 300bb–2— Continuation coverage
- § 300bb–3— Qualifying event
- § 300bb–4— Applicable premium
- § 300bb–5— Election
- § 300bb–6— Notice requirements
- § 300bb–7— Enforcement
- § 300bb–8— Definitions
- § 300cc–1— Requirement of expediting awards of grants and contracts for research
- § 300cc–2— Requirements with respect to processing of requests for personnel and administrative support
- § 300cc–3— Establishment of Research Advisory Committee
- § 300cc–11— Clinical evaluation units at National Institutes of Health
- § 300cc–12— Use of investigational new drugs with respect to acquired immune deficiency syndrome
- § 300cc–13— Terry Beirn Community-Based AIDS Research Initiative
- § 300cc–14— Evaluation of certain treatments
- § 300cc–15— Support of international efforts
- § 300cc–16— Research centers
- § 300cc–17— Information services
- § 300cc–18— Development of model protocols for clinical care of infected individuals
- § 300cc–19— National blood resource education program
- § 300cc–20— Additional authority with respect to research
- § 300cc–31— Fellowships and training
- § 300cc–40— Establishment of Office
- § 300cc–40a— Microbicide research
- § 300cc–40b— Advisory Council; coordinating committees
- § 300cc–40c— Comprehensive plan for expenditure of appropriations
- § 300cc–41— Additional authorities
- § 300cc–43— Emergency Discretionary Fund
- § 300cc–45— General provisions regarding Office
- § 300cc–51— Definitions
- § 300dd–21— Demonstration projects
- § 300dd–31— Grants for anonymous testing
- § 300dd–32— Requirement of provision of certain counseling services
- § 300dd–33— Funding
- § 300ee— Use of funds
- § 300ee–1— Establishment of office with respect to minority health and acquired immune deficiency syndrome
- § 300ee–2— Information for health and public safety workers
- § 300ee–3— Continuing education for health care providers
- § 300ee–4— Technical assistance
- § 300ee–5— Use of funds to supply hypodermic needles or syringes for illegal drug use; prohibition
- § 300ee–11— Establishment of program
- § 300ee–12— Provisions with respect to carrying out purpose of grants
- § 300ee–13— Requirement of submission of application containing certain agreements and assurances
- § 300ee–14— Restrictions on use of grant
- § 300ee–15— Requirement of reports and audits by States
- § 300ee–16— Additional required agreements
- § 300ee–17— Determination of amount of allotments for States
- § 300ee–18— Failure to comply with agreements
- § 300ee–19— Prohibition against certain false statements
- § 300ee–20— Technical assistance and provision by Secretary of supplies and services in lieu of grant funds
- § 300ee–21— Evaluations
- § 300ee–22— Report by Secretary
- § 300ee–23— Definition
- § 300ee–24— Funding
- § 300ee–31— Availability of information to general public
- § 300ee–32— Public information campaigns
- § 300ee–33— Provision of information to underserved populations
- § 300ee–34— Authorization of appropriations
- § 300ff— Purpose
- § 300ff–1— Prohibition on use of funds
- § 300ff–11— Establishment of program of grants
- § 300ff–12— Administration and planning council
- § 300ff–13— Type and distribution of grants
- § 300ff–14— Use of amounts
- § 300ff–15— Application
- § 300ff–16— Technical assistance
- § 300ff–17— Definitions
- § 300ff–19— Establishment of program
- § 300ff–20— Authorization of appropriations
- § 300ff–21— Grants
- § 300ff–22— General use of grants
- § 300ff–23— Grants to establish HIV care consortia
- § 300ff–24— Grants for home- and community-based care
- § 300ff–25— Continuum of health insurance coverage
- § 300ff–26— Provision of treatments
- § 300ff–27— State application
- § 300ff–27a— Spousal notification
- § 300ff–28— Distribution of funds
- § 300ff–29— Technical assistance
- § 300ff–29a— Supplemental grants
- § 300ff–30— Emerging communities
- § 300ff–31a— Timeframe for obligation and expenditure of grant funds
- § 300ff–31b— Authorization of appropriations
- § 300ff–33— Early diagnosis grant program
- § 300ff–34— Perinatal transmission of HIV/AIDS; contingent requirement regarding State grants under this part
- § 300ff–37— State HIV testing programs established prior to or after May 20, 1996
- § 300ff–37a— Recommendations for reducing incidence of perinatal transmission
- § 300ff–38— Grants for partner notification programs
- § 300ff–51— Establishment of a program
- § 300ff–52— Minimum qualifications of grantees
- § 300ff–53— Preferences in making grants
- § 300ff–54— Miscellaneous provisions
- § 300ff–55— Authorization of appropriations
- § 300ff–61— Confidentiality and informed consent
- § 300ff–62— Provision of certain counseling services
- § 300ff–63— Applicability of requirements regarding confidentiality, informed consent, and counseling
- § 300ff–64— Additional required agreements
- § 300ff–65— Requirement of submission of application containing certain agreements and assurances
- § 300ff–66— Provision by Secretary of supplies and services in lieu of grant funds
- § 300ff–67— Use of funds
- § 300ff–71— Grants for coordinated services and access to research for women, infants, children, and youth
- § 300ff–81— Coordination
- § 300ff–82— Audits
- § 300ff–83— Public health emergency
- § 300ff–84— Prohibition on promotion of certain activities
- § 300ff–85— Privacy protections
- § 300ff–86— GAO report
- § 300ff–87— Severity of need index
- § 300ff–87a— National HIV/AIDS testing goal
- § 300ff–88— Definitions
- § 300ff–101— Special projects of national significance
- § 300ff–111— HIV/AIDS communities, schools, and centers
- § 300ff–121— Minority AIDS initiative
- § 300ff–131— Infectious diseases and circumstances relevant to notification requirements
- § 300ff–132— Routine notifications with respect to airborne infectious diseases in victims assisted
- § 300ff–133— Request for notification with respect to victims assisted
- § 300ff–134— Procedures for notification of exposure
- § 300ff–135— Notification of employee
- § 300ff–136— Selection of designated officers
- § 300ff–137— Limitation with respect to duties of medical facilities
- § 300ff–138— Miscellaneous provisions
- § 300ff–139— Injunctions regarding violation of prohibition
- § 300ff–140— Applicability of part
- § 300gg— Fair health insurance premiums
- § 300gg–1— Guaranteed availability of coverage
- § 300gg–2— Guaranteed renewability of coverage
- § 300gg–3— Prohibition of preexisting condition exclusions or other discrimination based on health status
- § 300gg–4— Prohibiting discrimination against individual participants and beneficiaries based on health status
- § 300gg–5— Non-discrimination in health care
- § 300gg–6— Comprehensive health insurance coverage
- § 300gg–7— Prohibition on excessive waiting periods
- § 300gg–8— Coverage for individuals participating in approved clinical trials
- § 300gg–9— Disclosure of information
- § 300gg–11— No lifetime or annual limits
- § 300gg–12— Prohibition on rescissions
- § 300gg–13— Coverage of preventive health services
- § 300gg–14— Extension of dependent coverage
- § 300gg–15— Development and utilization of uniform explanation of coverage documents and standardized definitions
- § 300gg–15a— Provision of additional information
- § 300gg–16— Prohibition on discrimination in favor of highly compensated individuals
- § 300gg–17— Ensuring the quality of care
- § 300gg–18— Bringing down the cost of health care coverage
- § 300gg–19— Appeals process
- § 300gg–19a— Patient protections
- § 300gg–19b— Information on prescription drugs
- § 300gg–21— Exclusion of certain plans
- § 300gg–22— Enforcement
- § 300gg–23— Preemption; State flexibility; construction
- § 300gg–25— Standards relating to benefits for mothers and newborns
- § 300gg–26— Parity in mental health and substance use disorder benefits
- § 300gg–27— Required coverage for reconstructive surgery following mastectomies
- § 300gg–28— Coverage of dependent students on medically necessary leave of absence
- § 300gg–41— Guaranteed availability of individual health insurance coverage to certain individuals with prior group coverage
- § 300gg–42— Guaranteed renewability of individual health insurance coverage
- § 300gg–43— Certification of coverage
- § 300gg–44— State flexibility in individual market reforms
- § 300gg–45— Relief for high risk pools
- § 300gg–46— Disclosure to enrollees of individual market coverage
- § 300gg–51— Standards relating to benefits for mothers and newborns
- § 300gg–52— Required coverage for reconstructive surgery following mastectomies
- § 300gg–53— Prohibition of health discrimination on the basis of genetic information
- § 300gg–54— Coverage of dependent students on medically necessary leave of absence
- § 300gg–61— Enforcement
- § 300gg–62— Preemption and application
- § 300gg–63— General exceptions
- § 300gg–91— Definitions
- § 300gg–92— Regulations
- § 300gg–93— Health insurance consumer information
- § 300gg–94— Ensuring that consumers get value for their dollars
- § 300gg–95— Uniform fraud and abuse referral format
- § 300gg–111— Preventing surprise medical bills
- § 300gg–112— Ending surprise air ambulance bills
- § 300gg–113— Continuity of care
- § 300gg–114— Maintenance of price comparison tool
- § 300gg–115— Protecting patients and improving the accuracy of provider directory information
- § 300gg–117— Other patient protections
- § 300gg–118— Air ambulance report requirements
- § 300gg–119— Increasing transparency by removing gag clauses on price and quality information
- § 300gg–120— Reporting on pharmacy benefits and drug costs
- § 300gg–121— Oversight of entities that provide pharmacy benefit management services
- § 300gg–131— Balance billing in cases of emergency services
- § 300gg–132— Balance billing in cases of non-emergency services performed by nonparticipating providers at certain participating facilities
- § 300gg–133— Provider requirements with respect to disclosure on patient protections against balance billing
- § 300gg–134— Enforcement
- § 300gg–135— Air ambulance services
- § 300gg–136— Provision of information upon request and for scheduled appointments
- § 300gg–137— Patient-provider dispute resolution
- § 300gg–138— Continuity of care
- § 300gg–139— Provider requirements to protect patients and improve the accuracy of provider directory information
- § 300hh— Public health and medical preparedness and response functions
- § 300hh–1— National Health Security Strategy
- § 300hh–2— Enhancing medical surge capacity
- § 300hh–3— Office of Pandemic Preparedness and Response Policy
- § 300hh–10— Coordination of preparedness for and response to all-hazards public health emergencies
- § 300hh–10a— Public Health Emergency Medical Countermeasures Enterprise
- § 300hh–10b— National Advisory Committee on Children and Disasters
- § 300hh–10c— National Advisory Committee on Seniors and Disasters
- § 300hh–10d— National Advisory Committee on Individuals With Disabilities and Disasters
- § 300hh–10e— Advisory Committee Coordination
- § 300hh–11— National Disaster Medical System
- § 300hh–13— Evaluation of new and emerging technologies regarding bioterrorist attack and other public health emergencies
- § 300hh–14— Protection of health and safety during disasters
- § 300hh–15— Volunteer Medical Reserve Corps
- § 300hh–16— At-risk individuals
- § 300hh–17— Emergency response coordination of primary care providers
- § 300hh–31— Epidemiology-laboratory capacity grants
- § 300hh–32— Enhanced support to assist health departments in addressing vector-borne diseases
- § 300hh–33— Public health data system modernization
- § 300hh–34— Genomic sequencing, analytics, and public health surveillance of pathogens program
- § 300hh–35— Epidemic forecasting and outbreak analytics
- § 300hh–36— Leadership exchange pilot for public health and medical preparedness and response positions at the Department of Health and Human Services
- § 300hh–37— One Health framework
- § 300ii— Definitions
- § 300ii–1— Lifespan respite care grants and cooperative agreements
- § 300ii–2— National lifespan respite resource center
- § 300ii–3— Data collection and reporting
- § 300ii–4— Authorization of appropriations
- § 300jj— Definitions
- § 300jj–11— Office of the National Coordinator for Health Information Technology
- § 300jj–12— Health Information Technology Advisory Committee
- § 300jj–13— Setting priorities for standards adoption
- § 300jj–14— Process for adoption of endorsed recommendations; adoption of initial set of standards, implementation specifications, and certification criteria
- § 300jj–15— Application and use of adopted standards and implementation specifications by Federal agencies
- § 300jj–16— Voluntary application and use of adopted standards and implementation specifications by private entities
- § 300jj–17— Federal health information technology
- § 300jj–18— Transitions
- § 300jj–19— Miscellaneous provisions
- § 300jj–19a— Electronic health record reporting program
- § 300jj–31— Immediate funding to strengthen the health information technology infrastructure
- § 300jj–32— Health information technology implementation assistance
- § 300jj–33— State grants to promote health information technology
- § 300jj–34— Competitive grants to States and Indian tribes for the development of loan programs to facilitate the widespread adoption of certified EHR technology
- § 300jj–35— Demonstration program to integrate information technology into clinical education
- § 300jj–36— Information technology professionals in health care
- § 300jj–37— General grant and loan provisions
- § 300jj–38— Authorization for appropriations
- § 300jj–51— Health information technology enrollment standards and protocols
- § 300jj–52— Information blocking
- § 300kk— Data collection, analysis, and quality
- § 300mm— Establishment of World Trade Center Health Program
- § 300mm–1— WTC Health Program Scientific/Technical Advisory Committee; WTC Health Program Steering Committees
- § 300mm–2— Education and outreach
- § 300mm–3— Uniform data collection and analysis
- § 300mm–4— Clinical Centers of Excellence and Data Centers
- § 300mm–5— Definitions
- § 300mm–21— Identification of WTC responders and provision of WTC-related monitoring services
- § 300mm–22— Treatment of enrolled WTC responders for WTC-related health conditions
- § 300mm–23— National arrangement for benefits for eligible individuals outside New York
- § 300mm–31— Identification and initial health evaluation of screening-eligible and certified-eligible WTC survivors
- § 300mm–32— Followup monitoring and treatment of certified-eligible WTC survivors for WTC-related health conditions
- § 300mm–33— Followup monitoring and treatment of other individuals with WTC-related health conditions
- § 300mm–41— Payment of claims
- § 300mm–42— Administrative arrangement authority
- § 300mm–51— Research regarding certain health conditions related to September 11 terrorist attacks
- § 300mm–52— World Trade Center Health Registry
- § 300mm–61— World Trade Center Health Program Fund
- § 300mm–62— Supplemental Fund
- § 300mm–63— Special Fund
- § 300mm–64— Pentagon/Shanksville Fund